Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Water Advocate Sharon Kleyne Introduces Dr. Philip Y. Paden's Research
  • USA - English


News provided by

Bio-Logic Aqua® Research – Water Life Science® -Rogue Media

Sep 14, 2017, 06:00 ET

Share this article

Share toX

Share this article

Share toX

Grants Pass, OR (PRWEB) September 14, 2017 -- International water researcher and educator, Sharon Kleyne, founder of Bio-Logic Aqua® Research Water Life Science® and host of the nationally syndicated The Sharon Kleyne Hour Power of Water, Global Climate Change and Your Health on VoiceAmerica sponsored by Nature’s Tears® EyeMist®, noted the corroborative research and findings of Dr. Philip Y. Paden, M.D. Dr. Paden conducted a several-year study of Bio-Logic Aqua® Research Water Life Science’s® Nature’s Tears® EyeMist® and arrived at some significant conclusions.

“I have given a sample,” said Dr. Paden, ”of Nature’s Tears® EyeMist®, from Bio-Logic Aqua® Research Water Life Science®, to 10 to 15 patients a day for the last nine years. All these patients had come to my ophthalmology office with complaints of dry, burning or irritated eyes and/or blurring or tearing while reading or using computers. The mist was given out along with a sample of artificial tear drops from various manufacturers. I am an enthusiastic investor in, and Medical Director of, Bio-Logic Aqua® Research Water Life Science® because of the feedback from these patients.

“To understand this feedback,” Paden continued, “one must realize that when addressing the very common complaints of burning, blurring, tearing, and irritated eyes, we are primarily treating subjective patient complaints and not objective ocular surface disease. These complaints are often the only reason that the patient called for an appointment. All patients were given a sample of artificial tear drops with their mist sample and many had tried one of more conventional products in the past, so much of the feedback was in comparison to the myriad of other products on the market. The most remarkable result of this informal sampling survey was patient enthusiasm. Feedback on all other drop, ointment, eyewash and nutritional supplement products for dry eye has always been lukewarm at best: ‘Better than nothing,’ ‘helps for a little while,’ or ‘doesn’t help.’ Nature’s Tears EyeMist inspired such comments as, ‘I love that stuff’ or ‘it’s better than all the other products’.”

Contributing to this patient enthusiasm, Paden explained, is the absence of burning, stinging, and blurring. All chemically compounded artificial tears cause these problems in certain patients due to the thickening polymers and chemical nature of these products. Because Natures Tears® EyeMist® is not a compounded product and contains only water, water pure enough to serve as a superior base for tissue culture media, this product cannot and does not cause burning, stinging, and blurring.

“Prior to the introduction of this product,” Paden said, “I never had an enthusiastic response to any dry eye product. Ophthalmologists and optometrists had been hoping for a better product because these unhappy patients are a several-times-a-day reality in our practices. Besides patient enthusiasm for the relief of symptoms offered by the mist, convenience of administration must be considered. One cannot safely instill artificial tear drops while driving on a busy freeway but misting in this situation is easy and not dangerous. None of the drops or ointment products offers the possibility of frequent, convenient dosing, and frequent dosing is the key to relief in many patients.”

Dr. Paden noted that Nature’s Tears EyeMist was offered to patients in addition to conventional products, not as a sole alternative. Many patients ultimately used both drops and mist in a way that maximized their relief. The polymer or gum component in drops results in a longer duration of relief and the mist is quick, easy and effective between drops. “I have found,” Paden said, “that Nature’s Tears EyeMist is an important complement to, and not a replacement for, other products on the market.”

Kleyne praised Dr. Paden’s dedication to improving dry eye health for everyone. “Experience with this product will show,” Paden concluded, “that while there are a few patients who can’t or won’t mist their eyes, the enthusiastic response of many others demonstrates that the market potential for Nature’s Tears® EyeMis®t is huge. No other product generates so much patient enthusiasm and no other product is as frequently described as “the most effective product available.”

Please visit http://www.biologicaqua.com for more information about new water research technology and a new Water Life Science® experience that awaits you.

Sharon Kleyne, Bio-Logic Aqua® Research – Water Life Science® -Rogue Media, http://www.biologicaqua.com, +1 (800) 367-6478, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.